Loading provider…
Loading provider…
Pulmonary Disease Physician in Kansas City, KS
NPI: 1396814430Primary Practice Location
UNIVERSITY OF KANSAS HOSPITAL
4000 Cambridge St, Kansas City, KS
Primary Employer
Ku Internal Medicine
kansashealthsystem.com
HQ Phone
Get MD Joel's Phone Numberphone_androidMobile
Get MD Joel's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardKS State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 94729Measurement of lung diffusing capacity | 84 | 84 |
| 2 | 94010Measurement and graphic recording of total and timed exhaled air capacity | 82 | 84 |
| 3 | 94726Determination of lung volumes using plethysmography | 69 | 69 |
| 4 | 99214Established patient office or other outpatient visit, 30-39 minutes | 62 | 85 |
| 5 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 56 | 119 |
HMG-CoA Reductase Inhibitors for Prevention and Treatment of Severe Sepsis.
Authors: Mermis, Joel D, Simpson, Steven Q
Journal: Curr Infect Dis Rep
Authors: Derek Low
Journal: Ann Am Thorac Soc
Physical Activity Level and Perception of Exercise in Cystic Fibrosis.
Authors: Burnett, David M, Barry, Ashley N, Mermis, Joel D
Journal: Respir Care
Publication Date: 2020-01-28
Lead Sponsor: Calithera Biosciences, Inc
Intervention / Treatment: DRUG: Placebos, DRUG: CB-280
Lead Sponsor: Savara Inc.
Intervention / Treatment: DRUG: Vancomycin inhalation powder, DRUG: Placebo inhalation powder
Lead Sponsor: Celtaxsys, Inc.
Intervention / Treatment: DRUG: Placebo, DRUG: CTX-4430